According to the Zhitong Finance App, Xiansheng Pharmaceutical (02096.HK) announced that on October 23, 2026, it would spend about HK$3.6324 million to repurchase 339,000 shares.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.